Similarly, in the AWARD-7 trial, dulaglutide was shown to preserve eGFR more effectively than insulin glargine over 52 weeks in patients with moderate-to-severe CKD, despite similar glycemic control [21]
GLP-1 receptor agonists such as Semaglutide (Wegovy, Ozempic) have sparked major changes in weight loss treatments
Phase II Study of Venetoclax Added to Cladribine (CLAD) and Low Dose AraC (LDAC) Alternating with 5-Azacytidine (AZA) in Older and Unfit Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)
Through gradual dose titration, patient education, and ongoing monitoring, clinicians can support safe long-term use of GLP-1 therapies while helping patients maintain the benefits of chronic treatment
Investigators found the same fungus in unopened vials and the cerebrospinal fluid of several patients, confirming that the fungus was the cause of the outbreak